🇺🇸 FDA
Patent

US 12331040

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

granted A61PA61P1/02A61P1/04

Quick answer

US patent 12331040 (Substituted benzofuranyl and benzoxazolyl compounds and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18